Penn Medicine looks at Immune Response to Coronavirus and prospects for reinfection.
Updated: Aug 27, 2020
People recovering from COVID-19, only to fall ill and test positive again — have stoked fears that immunity to the novel coronavirus might be short-lived. E. John Wherry, PhD, chair of Systems Pharmacology and Translational Therapeutics and director of the Institute for Immunology at Penn Medicine talks about the reports of reinfection and immune responses. To learn more, click Here
